|
SLC25A5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.90260000002096E-06 |
| Normal-vs-Stage3 |
4.32729999999548E-06 |
| Normal-vs-Stage4 |
1.27190036280922E-10 |
| Stage1-vs-Stage2 |
5.789200E-01 |
| Stage1-vs-Stage3 |
1.409190E-01 |
| Stage1-vs-Stage4 |
3.374200E-01 |
| Stage2-vs-Stage3 |
5.965000E-01 |
| Stage2-vs-Stage4 |
2.581400E-01 |
| Stage3-vs-Stage4 |
5.508400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.23785484271866E-14 |
| Normal-vs-Asian |
7.651600E-02 |
| Caucasian-vs-AfricanAmerican |
4.082400E-01 |
| Caucasian-vs-Asian |
6.839000E-01 |
| AfricanAmerican-vs-Asian |
9.046800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.85007564823536E-12 |
| Male-vs-Female |
7.788400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.20420004260325E-09 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.62725388719309E-12 |
| Normal-vs-Extreme_Obese |
3.120400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.522800E-01 |
| Normal_Weight-vs-Obese |
8.581000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.510400E-01 |
| Extreme_Weight-vs-Obese |
5.313600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.140600E-01 |
| Obese-vs-Extreme_Obese |
4.117200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.09939868109655E-11 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.33226762955019E-15 |
| Normal-vs-Age(81-100Yrs) |
3.78969999825784E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.253600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.760000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.390200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.325030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.978600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.733000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
5.73729999953088E-07 |
| Normal-VS-KIRP CIMP |
1.70674585575625E-12 |
| Normal-VS-Unclassified PRCC |
1.66955338443131E-12 |
| Type1 PRCC-VS-Type2 PRCC |
5.77470000040492E-07 |
| Type1 PRCC-VS-KIRP CIMP |
7.561600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.509850E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.09320047143081E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
6.624100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.791220E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.45901085552214E-12 |
| Normal-vs-N1 |
2.02829975037844E-11 |
| Normal-vs-N2 |
1.62559999999923E-05 |
| N0-vs-N1 |
3.927200E-01 |
| N0-vs-N2 |
5.946400E-01 |
| N1-vs-N2 |
8.873800E-01 |
|
|
